Ceribell, Inc. income statement

In fiscal 2025, Ceribell, Inc. reported revenue of $89.1m, up 36.1% on the year before, operating income of −$58.4m (a -65.6% margin) and net income of −$53.4m, or −$1.46 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Ceribell, Inc.: income statement, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	45	65	89	102
Cost of revenue	7	9	11	11
Gross profit	38	57	78	91
Research and development	9	14	19	23
Selling and marketing	39	49	73	84
General and administrative	20	34	44	53
Operating income	−30	−40	−58	−70
Interest expense	2	2	2	2
Income before tax	−29	−40	−53	−66
Income tax	0	0	0	—
Net income	−29	−40	−53	−66
Diluted EPS	−$1.85	−$1.13	−$1.46	−$1.76
Diluted shares (average)	16m	36m	37m	37m
EBITDA	−29	−39	−57	−69

US$ millions unless shown otherwise. Fiscal quarters.

Ceribell, Inc.: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	17	19	20	21	23	25	26	28
Cost of revenue	2	2	2	3	3	3	3	2
Gross profit	15	16	18	19	20	22	23	26
Research and development	3	4	4	5	5	5	6	7
Selling and marketing	13	15	18	17	19	19	22	24
General and administrative	9	10	10	11	11	12	15	15
Operating income	−10	−13	−14	−15	−15	−15	−21	−20
Interest expense	1	0	0	0	0	0	0	0
Income before tax	−10	−13	−13	−14	−13	−14	−20	−19
Income tax	—	—	—	0	—	—	—	0
Net income	−10	−13	−13	−14	−13	−14	−20	−19
Diluted EPS	−$1.85	$1.63	−$0.36	−$0.38	−$0.37	−$0.36	−$0.52	−$0.51
EBITDA	−10	−13	−14	−15	−14	−14	−21	−20

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CBLL vs DCTH CBLL vs XTNT CBLL vs SMTI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Ceribell, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ceribell, Inc.